SPATA19 antibody (N-Term)
Quick Overview for SPATA19 antibody (N-Term) (ABIN1450102)
Target
See all SPATA19 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- SPATA19 antibody was raised against an 17 amino acid synthetic peptide near the amino terminus of human SPATA19.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- SPATA19 (Spermatogenesis Associated 19 (SPATA19))
-
Alternative Name
- SPATA19 / SPERGEN1
-
Background
- SPATA19, also known as SPERGEN1, was initially identified as a testis-specific protein that localizes to the surface of mitochondria in the middle piece of mature spermatozoa. Recent experiments have shown that elevated levels of SPATA19 have been found in basal cell carcinomas and prostate cancers, suggesting that SPATA19 may serve as a putative cancer biomarker and a target for cancer immunotherapy.Synonyms: FLJ25851, SPAS1, Spergen-1, Spermatogenesis-associated protein 19, Spermatogenic cell-specific gene 1 protein
-
Gene ID
- 219938
Target
-